+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex



Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex



Journal of Neurodegenerative Diseases 2013: 679089



Objective. Amyotrophic lateral sclerosis/parkinsonism-dementia complex is classified as one of the tauopathies. Methods. The total tau, phosphorylated tau, and amyloid β42 levels were assayed in cerebrospinal fluid from patients with Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex (n = 12), Alzheimer's disease (n = 9), Parkinson's disease (n = 9), amyotrophic lateral sclerosis (n = 11), and controls (n = 5) using specific enzyme-linked immunosorbent assay methods. Results. Total tau and phosphorylated tau did not increase and amyloid β42 was relatively reduced in Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex. Relatively reduced amyloid β42 might discriminate Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex from amyotrophic lateral sclerosis and Parkinson's disease, and the ratios of phosphorylated-tau to amyloid β42 could discriminate Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex from Alzheimer's disease. Conclusions. Cerebrospinal fluid analysis may be useful to differentiate amyotrophic lateral sclerosis/parkinsonism-dementia complex from Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 057374035

Download citation: RISBibTeXText

PMID: 26316995

DOI: 10.1155/2013/679089


Related references

Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid. Archives of Neurology 25(1): 9-13, 1971

Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-Parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology. Journal of Clinical Pathology. Supplement 6: 132-140, 1972

Ubiquitin immunoreactivity in dentate granular cells in Guamanian amyotrophic lateral sclerosis and Guamanian parkinsonism-dementia complex Comparative study to amyotrophic lateral sclerosis with dementia. Brain Pathology 7(4): 1173, 1997

Comparative study of ubiquitin immunoreactivity of hippocampal granular cells in amyotrophic lateral sclerosis with dementia, Guamanian amyotrophic lateral sclerosis and Guamanian parkinsonism-dementia complex. Acta Neuropathologica. 93(3): 265-270, 1997

Studies on amyotrophic lateral sclerosis by neutron activation analysis 3. systematic analysis of metals on guamanian amyotrophic lateral sclerosis and parkinsonism dementia complex cases. Folia Psychiatrica et Neurologica Japonica 36(2): 173-180, 1982

Amyotrophic lateral sclerosis Parkinsonism-dementia complex on Guam. Stern, M B , Koller, W C Neurological Disease and Therapy; Parkinsonian syndromes : 279-294, 1993

Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam. Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 136-140, 2004

Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Esiri, M M, Morris, J H The neuropathology of dementia: 194-203, 1997

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Annals of Neurology 58(5): 803-807, 2005

Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathologica 115(1): 133-145, 2007

Amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii Peninsula of Japan. Rinsho Shinkeigaku 42(11): 1073-1076, 2003

Amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan. Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 141-146, 2004

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Annals of Neurology 83(2): 258-268, 2018

Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex. Lancet 343(8897): 611, 1994

Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam: immunohistochemical studies. Keio Journal of Medicine 41(1): 6-9, 1992